ZA919076B - Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids - Google Patents

Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids

Info

Publication number
ZA919076B
ZA919076B ZA919076A ZA919076A ZA919076B ZA 919076 B ZA919076 B ZA 919076B ZA 919076 A ZA919076 A ZA 919076A ZA 919076 A ZA919076 A ZA 919076A ZA 919076 B ZA919076 B ZA 919076B
Authority
ZA
South Africa
Prior art keywords
acids
alpha
hydroxyalkane
complexes containing
phenyl alkane
Prior art date
Application number
ZA919076A
Other languages
English (en)
Inventor
Henrich Hasko Paradies
Hasko Paradies Henrich
Original Assignee
Puetter Medice Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puetter Medice Chem Pharm filed Critical Puetter Medice Chem Pharm
Publication of ZA919076B publication Critical patent/ZA919076B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
ZA919076A 1990-11-15 1991-11-15 Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids ZA919076B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036459 1990-11-15

Publications (1)

Publication Number Publication Date
ZA919076B true ZA919076B (en) 1992-08-26

Family

ID=6418340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919076A ZA919076B (en) 1990-11-15 1991-11-15 Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids

Country Status (18)

Country Link
US (1) US5254728A (hu)
EP (1) EP0486964B1 (hu)
JP (1) JPH0656738A (hu)
KR (1) KR920009767A (hu)
CN (1) CN1061405A (hu)
AT (1) ATE137487T1 (hu)
AU (1) AU643168B2 (hu)
BG (1) BG95488A (hu)
BR (1) BR9104995A (hu)
CA (1) CA2055682A1 (hu)
CS (1) CS346691A3 (hu)
DE (2) DE4137699A1 (hu)
ES (1) ES2089091T3 (hu)
HU (1) HUT59653A (hu)
MX (1) MX9102087A (hu)
NZ (1) NZ240618A (hu)
PL (1) PL292414A1 (hu)
ZA (1) ZA919076B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
JP4707201B2 (ja) * 1997-02-04 2011-06-22 千寿製薬株式会社 ピリドンカルボン酸の可溶化方法、その可溶化剤および可溶化されたピリドンカルボン酸からなる水性液剤
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
JP2011500724A (ja) * 2007-10-19 2011-01-06 パーデュ リサーチ ファンデーション 結晶性化合物の固体製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166447B (hu) * 1985-11-27 1990-05-12 Ethicon Inc
DE3836863A1 (de) * 1988-10-27 1990-05-03 Klosa Josef Fluessige, geloeste antirheumatische arzneizubereitungen
EP0424028B1 (en) * 1989-10-17 1995-09-27 Merck & Co. Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
US5254728A (en) 1993-10-19
DE59107762D1 (de) 1996-06-05
EP0486964B1 (de) 1996-05-01
CN1061405A (zh) 1992-05-27
AU8790991A (en) 1992-05-21
BR9104995A (pt) 1992-06-23
EP0486964A2 (de) 1992-05-27
KR920009767A (ko) 1992-06-25
ATE137487T1 (de) 1996-05-15
CA2055682A1 (en) 1992-05-16
HUT59653A (en) 1992-06-29
DE4137699A1 (de) 1992-05-27
BG95488A (bg) 1993-12-24
PL292414A1 (en) 1992-10-19
CS346691A3 (en) 1992-06-17
NZ240618A (en) 1994-10-26
MX9102087A (es) 1992-10-30
HU913573D0 (en) 1992-01-28
EP0486964A3 (en) 1992-12-16
JPH0656738A (ja) 1994-03-01
ES2089091T3 (es) 1996-10-01
AU643168B2 (en) 1993-11-04

Similar Documents

Publication Publication Date Title
HU911815D0 (en) Process for the production of medical preparations containing pravastatine for the prevention of, relapse after vasodilator operation
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
AU2982889A (en) Novel dosage form of fenofibrate
AU2292288A (en) Rapid recoverable ptfe & process therefor
PL297610A1 (hu)
HU913216D0 (en) Process for the production of saturated hydroxy-alkyl-kinoline acids, and of medical preparations containing them
NL8901652A (nl) Carboxamideverbindingen, werkwijzen ter bereiding hiervan en farmaceutische preparaten, die deze bevatten.
EP0044453A3 (en) New benzisoselenazolones, process for producing the same and pharmaceutical preparations containing the same
HU910929D0 (en) Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them
HU892994D0 (en) Process for the production of stabil medical preparations
EP0277612A3 (en) Substituted 3,4-dihydro-2h-benzopyranes, process for their preparation, their use and pharmaceutical preparations based on these compounds
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
ZA853351B (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it
ZA821637B (en) Oxazaphosphorin-4-thio-alkanesulfonic acids, neutral salts thereof, processes for the production thereof and pharmaceutical preparations containing them
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
HU911750D0 (en) Process for the production of medical preparations containing substituted betha-hydroxy-ethylamines
HU9102385D0 (en) Process for the production of medical preparations
ZA919076B (en) Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids
AU1004588A (en) Solution ibuprofen complexes, compositions and processes for preparing same
GB8807097D0 (en) Beauty preparations having anti-fading effect & process for preparing same
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
HU912517D0 (en) New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
EP0315536A3 (fr) Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
ES8601694A1 (es) Procedimiento para preparar un compuesto de inclusion a base de n,n-dimetil-2-cloro-5(3-metil-2-(fenilimino)-4-tiazolin-4-il)-fenilsulfonamida y b-ciclodextrina